Publications

Selected Refereed Publications (2000 - present)

1. Dreon, D.M., H.A. Fernstrom, P.T. Williams, and R.M. Krauss. Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns. Amer. J. Clin. Nutr. 71:1611-1616, 2000.
   
   
2. Kritchevsky, D., S.A. Tepper, S.C. Chen, G.W. Meijer, and R.M. Krauss. Cholesterol vehicle in experimental atherosclerosis. 23. Effects of specific synthetic triglycerides. Lipids 35:621-625, 2000.
   
   
3. Zhu, Y., M.C. Jong, K.A. Frazer, E. Gong, R.M. Krauss, J.-F. Cheng, D. Boffelli, and R.M. Rubin.  Genomic interval engineering of mice identifies a novel modulator of triglyceride production.  PNAS, 97(3):1137-1142, 2000.
   
   
4. Tribble, D.L., R.M. Krauss, B.M. Chu, E.L. Gong, B.R. Kullgren, J.O. Nagy, and M. La Belle.  Increased low density lipoprotein degradation in aorta or irradiated mice is inhibited by preenrichment of low density lipoprotein with alpha-tocopherol.  J. Lipid Res. 41: 1666-1672, 2000.
   
   
5. Tribble, D.L., M. Rizzo, A. Chait, D.M. Lewis, P.J. Blanche, R.M. Krauss.  Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense, low-density lipoproteins. Am. J. Med., 110(2): 103-110, 2001.
   
   
6. Pennacchio, L.A., M. Olivier, J,A. Hubacek, J.C. Cohen, D.R. Cox, H.-C. Fruchart, R.M. Krauss, E.M. Rubin.  An apolipoprotein identified through comparative sequence analysis that influences triglyceride levels in humans and mice.  Science. 294:169-173, 2001.
   
   
7. Campos, E., L. Kotite, P. Blanche, Y. Mitsugi, P.H. Frost, U. Masharani, R.M. Krauss, R.J. Havel. Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma.  J. Lipid Res. 43:365-374, 2002.
   
   
8. Berneis, K. and R.M. Krauss.  Metabolic origins and clinical significance of LDL heterogeneity.  J. Lipid Res.  43:1363-79, 2002.
   
   
9. Olin-Lewis, K., R.M. Krauss, M. La Belle, P.J. Blanche, P.H.R. Barrett, T.N. Wight and A. Chait.  Apo C-III Content of Apo B-Containing Lipoproteins is Associated with Binding to the Vascular Proteoglycan, Biglycan. J. Lipid Res. 43:1969-1977, 2002.
   
   
10. Pennachio, L.A., M. Olivier, J.A. Hubacek, R.M. Krauss, E.M. Rubin and J.C. Cohen.  Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.  Hum. Mol. Gen. 11:3031-38, 2002.
    
    
11. Attie, A.D., R.M. Krauss, M.P. Gray-Keller, A. Brownlie, M. Miyazaki, J.J. Kastelein, A.J. Lusis, A.F.H. Stalehnhoef, J.P. Stoehr, M.R. Hayden and J.M. Ntambi.  Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia.  J. Lipid Res.  43:1899-1907, 2002.
    
    
12. Williams, P.T., H.R. Superko, W.L. Haskell, E.L. Alderman, P.J. Blanche, L.G. Holl and R.M. Krauss.  Smallest LDL particles are most strongly related to Coronary Disease Progression in Men. Arterioscler. Thromb. Vasc. Biol.  23:314-21, 2003.
    
    
13. Goodarzi, M.O., X. Guo, K.D.Taylor, M.J.Quinones, C. Samayoa, H. Yang, M.F. Saad, A. Palotie, R.M. Krauss, W.A. Hsueh, and J.I. Rotter. Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med. 5:322-327, 2003.
    
    
14. Rizzo, M., J.M. Taylor,  C.M. Barbagallo,  K. Berneis,  P.J. Blanche and R.M. Krauss.  Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits. Arterioscler Thromb Vasc Biol. 24:141-146, 2004.
    
    
15. Farahani, P., S. Chiu, C.L. Bowlus, D. Boffelli, E. Lee, J.S. Fisler, R.M. Krauss and C.H. Warden.  Obesity in BSB Mice is Correlated with Expression of Genes for Iron Homeostasis and Leptin.  Obesity Research . 12:191-204, 2004.
    
    
16. Berneis, K., D.M. Shames, P.J. Blanche, M. La Belle, M. Rizzo and R.M. Krauss.  Plasma clearance of human low-density lipoprotein in human apolipoprotein B transgenic mice is related to particle diameter.  Metabolism.  53:483-87, 2004.
    
    
17. Sattler, F.R., E.T. Schroeder, M.P. Dube, S.V. Jaque, C. Martinez, P.J. Blanche,  S. Azen and R.M. Krauss.  Metabolic effects of nandrolone decanoate and resistance training in men with HIV.  Am J Physiol Endocrinol Metab, 283: E1214-E1222, 2002.
    
    
18. Williams, P.T., P.J. Blanche, R.S. Rawlings and R.M. Krauss.  Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels.  Am J Clin Nutr, 82:181-7, 2005.
    
    
19. Williams, P.T., P.J. Blanche and R.M. Krauss.  Behavioral versus genetic correlates of lipoproteins and adiposity in identical twins discordant for exercise.  Circulation. 112:350-356, 2005.
    
    
20. McLaughlin, T, G. Reaven, F. Abbasi, C. Lamendola, M. Saad, D. Waters, J. Simon and R.M. Krauss.  Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?  Am. J. Cardiol. 96:399-404, 2005.
    
    
21. Krauss, R.M.  Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 25:2265-2272, 2005.
    
    
22. Barter, P.J., C.M. Ballantyne, R. Carmena, M. Castro Cabezas, M. John Chapman, P. Couture, J. De Graff, P.N. Durrington, O. Faergeman, J. Frohlich, C.D. Furberg, C. Gagne, S.M. Haffner, S.E. Humphries, I. Jungner, R.M. Krauss, P. Kwiterovich, S. Marconiva, C.J. Packard, T.A. Pearson, K. Srinath Reddy, R. Rosenson, N. Sarrafzadegan, A.D. Sniderman, A.F. Stalenhoef, E. Stein, P.J. Talmud, A.M. Tonkin, G. Walldius and K.M.S. Williams.  Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.  J. Internal Medicine. 259:247-258, 2006.
    
    
23. Krauss, R.M., P.J. Blanche, R.S. Rawlings, H.S. Fernstrom and P.T. Williams.  Separate effects of reduced carbohydrate and weight loss on atherogenic dyslipidemia. Am J Clin Nutr., in press.
    
    
24. Simon, J.A., F. Lin, S.B. Hulley, P.J. Blanche, D. Waters, S. Shiboski, J.I. Rotter, D.A. Nickerson, H. Yang, M. Saad and R.M. Krauss.  Phenotypic predictors of response to simvastatin therapy among African Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiology. In Press. 
    
    
25. Barter, P.J., C.M. Ballantyne, R. Carmena, M. Castro Cabezas, M. John Chapman, P. Couture, J. De Graff, P.N. Durrington, O. Faergeman, J. Frohlich, C.D. Furberg, C. Gagne, S.M. Haffner, S.E. Humphries, I. Jungner, R.M. Krauss, P. Kwiterovich, S. Marconiva, C.J. Packard, T.A. Pearson, K. Srinath Reddy, R. Rosenson, N. Sarrafzadegan, A.D. Sniderman, A.F. Stalenhoef, E. Stein, P.J. Talmud, A.M. Tonkin, G. Walldius and K.M.S. Williams.  Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.  J. Internal Medicine. 259:247-258, 2006.
    
    
26. Jacobs, K.A., R.M. Krauss, J.A. Fattor, M.A. Horning, A.L. Friedlander, T.A. Bauer, T.A. Hagobian, E.E. Wolfel and G.A. Brooks.  Endurance training has little effect on active muscle free fatty acid, lipoprotein cholesterol or triglyceride net balances.   Am J Physiol Endocrin Metabl. 291:E656-65, 2006.

Selected Book Chapters, Proceedings, Reports, and Editorials